One of issue on AC8 is it does not have actual control on research development, it all relies on the JV and partnership, itself sounds more like a drug reseller rather than an actual R&D company. This has a big risky to investors, what if AC8's key prioritized objective does not fit to the prioritize of its partners? Other real concern is the CEO of AC8, the daughter and father, are both basically avocado farmers and have no knowledge on either growing or cannabis medicine, and to me how this going to work is a myth.
- Forums
- ASX - By Stock
- Why the 6% drop today - with no news
One of issue on AC8 is it does not have actual control on...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable